Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2006 1
2009 2
2010 1
2011 1
2012 1
2013 1
2014 2
2017 1
2018 8
2019 5
2020 5
2021 8
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Top product forecasts for 2022.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2022 Jan;21(1):11. doi: 10.1038/d41573-021-00211-7. Nat Rev Drug Discov. 2022. PMID: 34893764 No abstract available.
Top product forecasts for 2021.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2021 Jan;20(1):10. doi: 10.1038/d41573-020-00219-5. Nat Rev Drug Discov. 2021. PMID: 33311581 No abstract available.
FDA new drug approvals in Q1 2022.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2022 May;21(5):329. doi: 10.1038/d41573-022-00063-9. Nat Rev Drug Discov. 2022. PMID: 35418706 No abstract available.
FDA new drug approvals in Q2 2022.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2022 Aug;21(8):550. doi: 10.1038/d41573-022-00123-0. Nat Rev Drug Discov. 2022. PMID: 35817940 No abstract available.
FDA new drug approvals in Q2 2023.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2023 Aug;22(8):614. doi: 10.1038/d41573-023-00117-6. Nat Rev Drug Discov. 2023. PMID: 37433940 No abstract available.
FDA new drug approvals in Q1 2023.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2023 May;22(5):346. doi: 10.1038/d41573-023-00065-1. Nat Rev Drug Discov. 2023. PMID: 37055583 No abstract available.
Top companies and drugs by sales in 2021.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2022 Apr;21(4):251. doi: 10.1038/d41573-022-00047-9. Nat Rev Drug Discov. 2022. PMID: 35277680 No abstract available.
Top companies and drugs by sales in 2022.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2023 Apr;22(4):260. doi: 10.1038/d41573-023-00039-3. Nat Rev Drug Discov. 2023. PMID: 36882626 No abstract available.
46 results